Joseph Aimi

    The Board of Directors, Medical Advisory Board, and staff of Cancer Research & Treatment Fund (CR&T) are deeply saddened by the loss of our board member, Joseph N. Aimi. As a longtime member of our board, Joe, and his wife, Terry, played a crucial role in building our organization and advancing our efforts to discover new treatments and cures for myeloproliferative neoplasms and other cancers. Joe arranged many charitable events benefiting CR&T, including golf outings, receiving CR&T’s Humanitarian Honoree Award in 2012 for his contributions. Joe’s commitment to our mission leaves a legacy that will benefit generations of cancer patients and their families. Our heartfelt condolences go to Terry and their family.

    LEARN MORE

    About CR&T

    Who We Are

    In 1968, Richard T. Silver, MD, a prominent hematologist-oncologist, founded the Cancer Research & Treatment Fund (CR&T) with the belief that investing in blood cancer research would lead to important breakthroughs, as well as a better understanding of the biology and treatment of all forms of cancer.  While the focus of the organization is the myeloproliferative neoplasms (MPNs), over the course of its 55-year history, CR&T has awarded more than $17 million in grants to research that has contributed to major advances in the fight against cancer.

    LEARN MORE

    Our Impact

    $ -1 M
    TO FUND
    BLOOD CANCER
    RESEARCH
    $ -1 M
    TO ESTABLISH
    THE DR. RICHARD
    T. SILVER CHAIR
    $ -1 M
    TO DOCTORS
    FOR OTHER
    CANCER RESEARCH

    Drs. Coleman and Leonard
    Pat Battle, Dr. Silver, Raphael Miranda
    Dr. Silver and Raphael Miranda
    Dr. Silver
    Raphael Miranda, Pat Battle,
    Drs. Silver, Leonard, Coleman
    Pat Battle and Dr. Silver
    The Cancer Research & Treatment Fund’s 12th International Patient Symposium on Myeloproliferative Neoplasms held at Weill Cornell Medicine Wednesday, Nov. 1, 2023, in New York. (AP Photo/John Munson)
    The Cancer Research & Treatment Fund’s 12th International Patient Symposium on Myeloproliferative Neoplasms held at Weill Cornell Medicine Wednesday, Nov. 1, 2023, in New York. (AP Photo/John Munson)
    The Cancer Research & Treatment Fund’s 12th International Patient Symposium on Myeloproliferative Neoplasms held at Weill Cornell Medicine Wednesday, Nov. 1, 2023, in New York. (AP Photo/John Munson)
    Untitled design (1)
    GHAITH ABU-ZEINAH, MD
    GHAITH ABU-ZEINAH, MD
    EDWARD P. AMBINDER, MD
    EDWARD P. AMBINDER, MD
    MORTON COLEMAN, MD, FACP
    MORTON COLEMAN, MD, FACP
    JOHN P. LEONARD, MD
    JOHN P. LEONARD, MD
    ANNE MOORE, MD
    ANNE MOORE, MD
    MALCOLM MOORE, DPhil
    MALCOLM MOORE, DPhil
    MARK PASMANTIER, MD
    MARK PASMANTIER, MD
    SHAHIN RAFII, MD
    SHAHIN RAFII, MD
    JOSEPH M. SCANDURA, MD, PhD
    JOSEPH M. SCANDURA, MD, PhD
    ANDREW I. SCHAFER, MD
    ANDREW I. SCHAFER, MD
    DAVID A. SCHEINBERG, MD, PhD
    DAVID A. SCHEINBERG, MD, PhD
    RICHARD T. SILVER, MD, FACP
    RICHARD T. SILVER, MD, FACP
    JERRY L. SPIVAK, MD
    JERRY L. SPIVAK, MD
    ALEXANDER J. SWISTEL, MD
    ALEXANDER J. SWISTEL, MD

    Medical Advisory Board

    At CR&T, our activities and funding objectives are guided by the expertise of a world-class Medical Advisory Board, featuring some of the world’s foremost physician-scientists in cancer treatment research.

    Meet Our MEDICAL ADVISORY BOARD

    Your gift today can help change a cancer patient's life.

    Microscope

    Looking for other ways you can give?

    https://www.crt.org/ways-to-give/